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 INTRODUCTION AND OBJECTIVES: A frequency/volume chart or bladder diary provides information to choose the 
appropriate therapy for children with nocturnal enuresis. Moreover, the chosen therapy can be evaluated using those diaries. The 
aim of this study is to identify possible predictive factors to predict response to desmopressin treatment. 
 METHODS: The study is a re-analyses of a international study evaluating ≤6 months treatment of children with primary 
nocturnal enuresis using desmopressin tablets. 471 children completed this prospective open-label study with 6 months follow-up 
and registration in a calendar. 
 RESULTS: Only the demographic variable age (p <0.001) is a significant predictors of response to desmopressin. 
Country, family history and sex had no predictive value. Controlling for age, significant predictive variables were: average daytime 
voided volume (p=0.0305), average daytime voided volume corrected for Hjalmas (p=0.0305), maximum daytime voided volume 
(p=0.0022), maximum 24h voided volume (p<0.0001), nocturnal diuresis (p<0.0001), nocturnal diuresis corrected for Rittig 
(p<0.0001), total 24h urinary output (p<0.0001), total daytime urinary output (p=0.0188), number of wet nights per week (p=0.0053). 
Three factors are of major concern to predict therapyoutcome of desmopressin: age, 24h urine output and number of wet nights a 
week. More than 80% of the patients had no nocturnal polyuria and a small bladder for age. 
 CONCLUSIONS: Most patients had no nocturnal polyuria and a small bladder for age, therefore the choosen therapy, 
desmopressin was not the appropriate therapy. The results clearly demonstrate the importance of a frequency/volume chart for 
patient selection in order to choose the appropriate therapy and to elevate the success rate. 
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